Correlation Between Algernon Pharmaceuticals and Biovaxys Technology

Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algernon Pharmaceuticals and Biovaxys Technology Corp, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Biovaxys Technology.

Diversification Opportunities for Algernon Pharmaceuticals and Biovaxys Technology

0.4

Correlation Coefficient

Algernon Pharmaceuticals  Biovaxys Technology

Very weak diversification

The 3 months correlation between Algernon and Biovaxys is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Biovaxys Technology go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Biovaxys Technology

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 1.29 times more return on investment than Biovaxys Technology. However, Algernon Pharmaceuticals is 1.29 times more volatile than Biovaxys Technology Corp. It trades about 0.03 of its potential returns per unit of risk. Biovaxys Technology Corp is currently generating about -0.04 per unit of risk. If you would invest  5.85  in Algernon Pharmaceuticals on October 26, 2024 and sell it today you would lose (0.24) from holding Algernon Pharmaceuticals or give up 4.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.16%
Values	Daily Returns

Algernon Pharmaceuticals  vs.  Biovaxys Technology Corp

Algernon Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Algernon Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Algernon Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Biovaxys Technology Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biovaxys Technology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Algernon Pharmaceuticals and Biovaxys Technology

The main advantage of trading using opposite Algernon Pharmaceuticals and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.

The idea behind Algernon Pharmaceuticals and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.